Scientific Publication:

SARS-CoV-2 Breakthrough Infections According to the Immune Response Elicited after mRNA Third Dose Vaccination in COVID-19-Naïve Hospital Personnel

Authors: 
Santoro Annapaola, Capri Andrea, Petrone Daniele, Colavita Francesca, Meschi Silvia, Matusali Giulia, Mizzoni Klizia, Notari Stefania, Agrati Chiara, Goletti Delia, Pezzotti Patrizio, Puro Vincenzo
Journal: 
Biomedicines
Date of publication: 
Sunday, 23 April, 2023
Volume: 
11
Issue: 
5
Pages: 
1247
Related DOI: 
10.3390/biomedicines11051247
EVAg connections: 
Research funded by EVAg
Related to EVAg product
Published by EVAg partner
This publication has been related to the following 1 product(s) of our catalogue

1 products displayed

SARS-CoV-2 virus, hCoV-19/Italy/L OM-INMI-10734/2 020, D614G (S) (clade G, lineage B.1)

Produced by:
INMI
Shipping From:
Roma - IT
virus
Ref-SKU:
008V-04005
Infectious cell culture supernatant containing SARS-CoV-2 isolate hCoV-19/Italy/LOM-INMI-10734/2020, D614G (S), clade G. This strain is preserved under Viral Storage Medium -80C and is Mycoplasma free.
Unit: 1 vial of 0.2 ml
Riboviria / Orthornavirae / Pisuviricota / Pisoniviricetes / Nidovirales / Cornidovirineae / Coronaviridae / Orthocoronavirinae / Betacoronavirus / Sarbecovirus / Severe acute respiratory syndrome-related coronavirus
Virus name: 
SARS-CoV-2
Strain: 
hCoV-19/Italy/LOM-INMI-10734/2020
Genotype: 
clade G, lineage B.1 (Pango v.4.3.1 PANGO-v1.23)


2 000,00 €
 (Cost per access for Academics)

View details...